| Name | LY3143921 hydrate |
|---|
| Description | LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. LY3143921 hydrate shows broad in vitro anticancer activity[1]. |
|---|---|
| Related Catalog | |
| Target |
Cdc7 |
| References |
[1]. Robert Dean Dally, et al. CDC7 Inhibitors. WO2014143601 A1. |
| Molecular Formula | C16H14FN5O2 |
|---|---|
| Molecular Weight | 327.31 |